C07F15/02

METHOD FOR DEGRADING ANTIBIOTICS BY AQUEOUS PHASE TRANSFER CATALYSIS USING AN ANIONIC LIQUID AND HYDROGEN PEROXIDE

Disclosed is a method for degrading antibiotics by aqueous phase transfer catalysis using an anionic liquid and hydrogen peroxide, including: adding hydrogen peroxide to a wastewater containing the antibiotics to obtain a first mixture, and adjusting a pH of the first mixture to 3-4 to form an aqueous phase, and adding a catalyst to a water-insoluble ionic liquid to obtain a second mixture, and stirring the second mixture to form an ionic liquid phase, wherein the catalyst is selected from the group consisting of ferrocene, iron dodecyl sulfonate, ferrous dodecyl sulfonate, and copper dodecyl sulfonate; and mixing the aqueous phase and the ionic liquid phase in a volume ratio of (8-11):1 to obtain a mixed phase, and stirring the mixed phase to degrade the antibiotics.

METHOD FOR DEGRADING ANTIBIOTICS BY AQUEOUS PHASE TRANSFER CATALYSIS USING AN ANIONIC LIQUID AND HYDROGEN PEROXIDE

Disclosed is a method for degrading antibiotics by aqueous phase transfer catalysis using an anionic liquid and hydrogen peroxide, including: adding hydrogen peroxide to a wastewater containing the antibiotics to obtain a first mixture, and adjusting a pH of the first mixture to 3-4 to form an aqueous phase, and adding a catalyst to a water-insoluble ionic liquid to obtain a second mixture, and stirring the second mixture to form an ionic liquid phase, wherein the catalyst is selected from the group consisting of ferrocene, iron dodecyl sulfonate, ferrous dodecyl sulfonate, and copper dodecyl sulfonate; and mixing the aqueous phase and the ionic liquid phase in a volume ratio of (8-11):1 to obtain a mixed phase, and stirring the mixed phase to degrade the antibiotics.

Oxo-nitrogenated iron complex, catalytic system comprising said oxo-nitrogenated iron complex and process for the (co)polymerization of conjugated dienes

Oxo-nitrogenated iron complex having general formula (I): in which: R.sub.1 and R.sub.2, identical or different, represent a hydrogen atom; or they are selected from linear or branched, optionally halogenated C.sub.1-C.sub.20, preferably C.sub.1-C.sub.15, alkyl groups, optionally substituted cycloalkyl groups, optionally substituted aryl groups; R.sub.3 represents a hydrogen atom, or it is selected from linear or branched, optionally halogenated C.sub.1-C.sub.20, preferably C.sub.1-C.sub.15 alkyl groups, optionally substituted cycloalkyl groups, optionally substituted aryl groups; X, identical or different, represent a halogen atom such as, for example, chlorine, bromine, iodine, preferably chlorine; or they are selected from. linear or branched C.sub.1-C.sub.20, preferably C.sub.1-C.sub.15, alkyl groups, —OCOR.sub.4 groups or —OR.sub.4 groups in which R.sub.4 is selected from linear or branched C.sub.1-C.sub.20, preferably C.sub.1-C.sub.15, alkyl groups; n is 2 or 3. Said oxo-nitrogenated iron complex having general formula (I) can be advantageously used in a catalytic system for the (co)polymerization of conjugated dienes. ##STR00001##

Selective, adsorbate-induced spin state changes in transition metal-based metal-organic frameworks

An adsorbate-selective metal organic framework includes a transition metal; and a plurality of organic molecules coordinated to the transition metal so as to preserve open coordination sites for selectively adsorbing molecules that have low-lying π* orbitals. The transition metal has a lowest energy spin state in the presence of the selectively adsorbed molecules that are strongly bonding to the transition metal through π-donating interactions which is different than the lowest energy spin state in the absence of these adsorbed molecules. The transition metal has also a lowest energy spin state in the presence of non-selected molecules that are weakly bonding to the transition metal through σ- and/or π-accepting and/or donating interactions.

Metal-nucleic acid nanoparticle, preparation method therefor and use thereof

The present application relates to a metal-nucleic acid nanoparticle which is a nanoparticle having a spherical structure formed by assembly of metal ions with nucleic acids via coordination. The preparation thereof is mixing a metal ion solution with a nucleic acid solution to obtain a mixture followed by vortex, heating, centrifugation, washing with water and resuspension to obtain the metal-nucleic acid nanoparticles.

Photochemical separations and compositions

Provided herein are photochemical separations. The methods herein can include exposing a first metal complex and a second metal complex to light to facilitate an irreversible chemical reaction to form a modified first metal complex. The modified first metal complex then may be separated from the second metal complex. Compositions also are provided.

DEPOLYMERIZATION OF OLIGOMERS AND POLYMERS COMPRISING CYCLOBUTANE UNITS
20230059241 · 2023-02-23 ·

Methods of polymer and/or oligomer depolymerization are described herein which, in some embodiments, enable facile polymer and/or oligomer decomposition under mild, non-energy intensive conditions. Briefly, a method of depolymerization comprises providing a reaction mixture comprising a transition metal catalyst, and a polymer or oligomer having a backbone including cyclobutane units, and decomposing the polymer or oligomer to provide diene monomer or alkene monomer.

Organometallic compounds useful for chemical phase deposition

A method for forming a metal-containing film includes: a) providing at least one substrate; b) delivering to said substrate at least one compound of Formula 1 in the gaseous phase, (R.sup.1R.sup.2R.sup.3 (Si))—Co(CO).sub.4 (Formula 1), wherein R.sup.1, R.sup.2 and R.sup.3 are independently selected lower alkyl groups; and c) simultaneously with or subsequently to step b), delivering to said substrate a co-reagent in the gaseous phase, the co-reagent being lower alcohol. Further, a method of selectively depositing a metal-containing film includes: a) providing at least two substrates comprising different materials, one of said at least two substrates has an affinity for Si and another of said at least two substrates has an affinity for CO; b) delivering to said substrates at least one compound of the Formula 1 in the gaseous phase; and c) simultaneously with or subsequently to step b), delivering to said at least two substrates at least one co-reagent in the gaseous phase.

Organometallic compounds useful for chemical phase deposition

A method for forming a metal-containing film includes: a) providing at least one substrate; b) delivering to said substrate at least one compound of Formula 1 in the gaseous phase, (R.sup.1R.sup.2R.sup.3 (Si))—Co(CO).sub.4 (Formula 1), wherein R.sup.1, R.sup.2 and R.sup.3 are independently selected lower alkyl groups; and c) simultaneously with or subsequently to step b), delivering to said substrate a co-reagent in the gaseous phase, the co-reagent being lower alcohol. Further, a method of selectively depositing a metal-containing film includes: a) providing at least two substrates comprising different materials, one of said at least two substrates has an affinity for Si and another of said at least two substrates has an affinity for CO; b) delivering to said substrates at least one compound of the Formula 1 in the gaseous phase; and c) simultaneously with or subsequently to step b), delivering to said at least two substrates at least one co-reagent in the gaseous phase.

Labelling compounds and their use in assays

The invention provides monoferrocenyl compounds of general formula I. The invention also provides substrates labelled with the compounds, functionalised derivatives of the compounds and methods of using the compounds, functionalised derivatives and labelled substrates in electrochemical assays.